Literature DB >> 7699090

Portal vein pulsatility in normal and cirrhotic adults without cardiac disease.

R H Wachsberg1, L Needleman, D J Wilson.   

Abstract

The literature indicates that Doppler demonstration of pulsatile flow in the portal vein suggests heart disease, and that retrograde transsinusoidal transmission of atrial pulsations is the mechanism. We noninvasively investigated portal vein pulsatility (PVP) in normal subjects and in patients with cardiac and liver disease, and performed invasive studies in cirrhotic humans and normal pigs. We found that accentuated PVP occurred in some normal subjects and in some patients with cirrhosis, and that mechanisms other than transsinusoidal transmission of atrial pulsations contributed to PVP. Determinants of PVP may include pulsatile portal inflow, transmission of pulsations from the vena cava (IVC) and location of the Doppler sample volume relative to the IVC.

Entities:  

Mesh:

Year:  1995        PMID: 7699090     DOI: 10.1002/jcu.1870230103

Source DB:  PubMed          Journal:  J Clin Ultrasound        ISSN: 0091-2751            Impact factor:   0.910


  10 in total

1.  Qualitative and quantitative analysis of portal Doppler waveform and a novel factor of portal pulsatility: Systolic spike wave.

Authors:  Hiroyuki Sugimoto; Tetsuya Kaneko Fjsum; Tsuyoshi Hatsuno; Shin Takeda; Soichiro Inoue; Akimasa Nakao
Journal:  J Med Ultrason (2001)       Date:  2002-09       Impact factor: 1.314

2.  Experimental evaluation of portal venous pulsatile flow synchronized with heartbeat intervals: effects of vascular clamping on portal hemodynamics.

Authors:  Yoshito Nihei; Hideki Sasanuma; Yoshikazu Yasuda
Journal:  J Med Ultrason (2001)       Date:  2012-07-19       Impact factor: 1.314

3.  Portal Venous Pulsatility Index: A Novel Biomarker for Diagnosis of High-Risk Nonalcoholic Fatty Liver Disease.

Authors:  Masoud Baikpour; Arinc Ozturk; Manish Dhyani; Nathaniel D Mercaldo; Theodore T Pierce; Joseph R Grajo; Anthony E Samir
Journal:  AJR Am J Roentgenol       Date:  2020-01-15       Impact factor: 3.959

Review 4.  Comprehensive Assessment of Fluid Status by Point-of-Care Ultrasonography.

Authors:  Eduardo R Argaiz; Abhilash Koratala; Nathaniel Reisinger
Journal:  Kidney360       Date:  2021-05-27

5.  Assessing Splanchnic Compartment Using Portal Venous Doppler and Impact of Adding It to the EVEREST Score for Risk Assessment in Heart Failure.

Authors:  Nadia Bouabdallaoui; William Beaubien-Souligny; Essaïd Oussaïd; Christine Henri; Normand Racine; André Y Denault; Jean L Rouleau
Journal:  CJC Open       Date:  2020-03-30

6.  Doppler Interrogation of the Femoral Vein in the Critically Ill Patient: The Fastest Potential Acoustic Window to Diagnose Right Ventricular Dysfunction?

Authors:  André Y Denault; Matthew P Aldred; Ali Hammoud; Yu Hao Zeng; William Beaubien-Souligny; Etienne J Couture; Stéphanie Jarry; Caroline E Gebhard; Stephane Langevin; Yoan Lamarche; Pierre Robillard
Journal:  Crit Care Explor       Date:  2020-09-28

Review 7.  Venous Excess Doppler Ultrasound for the Nephrologist: Pearls and Pitfalls.

Authors:  Abhilash Koratala; Nathaniel Reisinger
Journal:  Kidney Med       Date:  2022-05-19

8.  Percentage of peak-to-peak pulsatility of portal blood flow can predict right-sided congestive heart failure.

Authors:  Jui-Ting Hu; Sien-Sing Yang; Yun-Chih Lai; Cheng-Yen Shih; Cheng-Wen Chang
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

9.  When the heart kills the liver: acute liver failure in congestive heart failure.

Authors:  F H Saner; M Heuer; M Meyer; A Canbay; G C Sotiropoulos; A Radtke; J Treckmann; S Beckebaum; C Dohna-Schwake; S W Oldedamink; A Paul
Journal:  Eur J Med Res       Date:  2009       Impact factor: 2.175

10.  Clinical applications of the venous excess ultrasound (VExUS) score: conceptual review and case series.

Authors:  Philippe Rola; Francisco Miralles-Aguiar; Eduardo Argaiz; William Beaubien-Souligny; Korbin Haycock; Timur Karimov; Vi Am Dinh; Rory Spiegel
Journal:  Ultrasound J       Date:  2021-06-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.